Oral dapoxetine versus topical lidocaine as on‐demand treatment for lifelong premature ejaculation: A randomised controlled trial
- 9 March 2020
- journal article
- research article
- Published by Hindawi Limited in Andrologia
- Vol. 52 (5) , e13558
Abstract
This trial aimed to assess the efficacy of on‐demand oral dapoxetine versus topical lidocaine treatments for lifelong PE. Cases with lifelong PE were randomised to start treatment by oral dapoxetine 60 mg or topical lidocaine 10% spray. The intravaginal ejaculatory latency time (ILET), validated Arabic Index for PE (AIPE), Sexual Health Inventory for Men (SHIM) and frequency of intercourse/week were recorded at the baseline and after 12 weeks treatment period of the first medication before two weeks washout period and then crossing over to the other one for another 12 weeks. Results showed that both medications significantly increased both IELT and AIPE scores compared with the baseline being significantly better with topical lidocaine (63.44 s, 179.4 s versus 21.87 s, p < .05). Significant decrease of SHIM score was recorded with lidocaine but not with dapoxetine. Global Efficacy Question for the patient's assessment of the effectiveness of drugs showed that lidocaine was described as being effective by 43 cases and ineffective by 12 cases, oral dapoxetine was described as being effective by 16 cases and ineffective by 39 cases. From these accumulated data, it is concluded that topical lidocaine is more effective on‐demand therapy for lifelong PE compared with oral dapoxetine.Keywords
This publication has 29 references indexed in Scilit:
- Hyaluronic acid injection in glans penis for treatment of premature ejaculation: a randomized controlled cross-over studyInternational Journal Of Impotence Research, 2019
- Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trialAndrologia, 2017
- On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: A randomised placebo-controlled clinical trialArab Journal of Urology, 2013
- Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled StudyThe Journal of Sexual Medicine, 2010
- PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double‐blind, placebo‐controlled studyBJU International, 2009
- Development and Evaluation of the Arabic Index of Premature Ejaculation (AIPE)The Journal of Sexual Medicine, 2007
- Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol‐delivery form of lidocaine‐prilocaine for treating premature ejaculationBJU International, 2006
- Topical anaesthetic use for treating premature ejaculation: a double‐blind, randomized, placebo‐controlled studyBJU International, 2004
- Topical lidocaine–prilocaine spray for the treatment of premature ejaculation: a proof of concept studyInternational Journal Of Impotence Research, 2003
- Optimum usage of prilocaine-lidocaine cream in premature ejaculationAndrologia, 2002